Health
Opinion: Egg-freezing boom exposes a profit-driven fertility industry
Why it matters
As more women consider egg freezing and advanced fertility treatments amid aggressive marketing, examining the commercial pressures behind these medical choices highlights critical ethical concerns in reproductive healthcare.
The brief
Public discussions surrounding political figures freezing their eggs have brought widespread attention to reproductive options, as reported by STAT News. However, an internal medicine physician and health policy specialist shared in STAT News that her own experience with an employer-subsidized egg freezing consultation involved intense body-shaming and pressure from her doctor to undergo the procedure immediately. Data published in the American Journal of Obstetrics and Gynecology indicates that the number of U.S. patients freezing their eggs grew rapidly from 4,153 in 2014 to 16,436 in 2021, while the average age of patients declined, according to STAT News.[1][2] Simultaneously, a separate STAT News investigation revealed that a controversial technique known as mitochondrial replacement therapy, or "three-parent IVF," is being marketed globally to older women as a fertility solution despite lacking sufficient evidence for treating age-related infertility.[3] STAT News reported that medical tourism facilitators connect patients in the United States and Europe to overseas clinics providing these procedures for tens of thousands of dollars.[4] While industry advocates point to positive drivers such as employer subsidies and heightened awareness, critics argue that commercial financialization exploits patients' anxieties about aging. It remains unconfirmed how widespread questionable record-keeping and misleading marketing practices are across the entire international fertility tourism market, according to reporting by STAT News.
What we don’t know yet
- Data published in the American Journal of Obstetrics and Gynecology indicates that the number of U.S. patients freezing their eggs grew from 4,153 in 2014 to 16,436 in 2021. Only statnews.com reports this so far.
- The average age of U.S. patients freezing their eggs declined between 2014 and 2021. Only statnews.com reports this so far.
- Mitochondrial replacement therapy, or three-parent IVF, is being marketed globally to older women as a fertility solution. Not yet confirmed by an independent source.
- Medical tourism facilitators connect patients in the United States and Europe to overseas clinics providing mitochondrial replacement therapy procedures for tens of thousands of dollars. Sources disagree on the details.
Quick answers
- What happened?
- Public discussions surrounding political figures freezing their eggs have brought widespread attention to reproductive options, as reported by STAT News. However, an internal medicine physician and health policy specialist shared in STAT News that her own experience with an employer-subsidized egg freezing consultation involved intense body-shaming and pressure from her doctor to undergo the procedure immediately. Data published in the American Journal of Obstetrics and Gynecology indicates that the number of U.S. patients freezing their eggs grew rapidly from 4,153 in 2014 to 16,436 in 2021, while the average age of patients declined, according to STAT News. Simultaneously, a separate STAT News investigation revealed that a controversial technique known as mitochondrial replacement therapy, or "three-parent IVF," is being marketed globally to older women as a fertility solution despite lacking sufficient evidence for treating age-related infertility. STAT News reported that medical tourism facilitators connect patients in the United States and Europe to overseas clinics providing these procedures for tens of thousands of dollars. While industry advocates point to positive drivers such as employer subsidies and heightened awareness, critics argue that commercial financialization exploits patients' anxieties about aging. It remains unconfirmed how widespread questionable record-keeping and misleading marketing practices are across the entire international fertility tourism market, according to reporting by STAT News.
- Why does it matter?
- As more women consider egg freezing and advanced fertility treatments amid aggressive marketing, examining the commercial pressures behind these medical choices highlights critical ethical concerns in reproductive healthcare.
- How was "Opinion: Egg-freezing boom exposes a profit-driven fertility industry" verified?
- Citelink grounded this brief in 2 sources, including STAT News. Every claim links to its citation in the sources list below.
Grounding — every claim checked against sources
Data published in the American Journal of Obstetrics and Gynecology indicates that the number of U.S. patients freezing their eggs grew from 4,153 in 2014 to 16,436 in 2021.
The average age of U.S. patients freezing their eggs declined between 2014 and 2021.
Mitochondrial replacement therapy, or three-parent IVF, is being marketed globally to older women as a fertility solution.
Medical tourism facilitators connect patients in the United States and Europe to overseas clinics providing mitochondrial replacement therapy procedures for tens of thousands of dollars.
Don't take our word for it
Run any claim in this Brief through Citelink's verification engine yourself.
Sources
How this brief was made
Citelink’s automated pipeline wrote this summary from the 2 sources listed above, then checked each claim against them before publishing. Briefs are not individually reviewed by a person before they go live, so read the original reporting for the full story.
Spotted an error? Request a correction · Corrections policy